- 专利标题： TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF
-
申请号： US15601617申请日： 2017-05-22
-
公开(公告)号： US20180052175A1公开(公告)日： 2018-02-22
- 发明人: Robert Arch , Jun Zhang , Michelle Mader , Tetsuya Ishino , Joel Bard , William Finlay , Orla Cunningham , Ciara Reilly , Peter Brams , Brigitte Devaux , Haichun Huang , Karla Henning
- 申请人： Pfizer Inc. , Bristol-Myers Squibb Company
- 主分类号： G01N33/68
- IPC分类号： G01N33/68 ; C07K16/28
摘要：
The present invention provides antibodies, or antigen-binding fragment thereof, which specifically bind to TL1A. The invention further provides a method of obtaining such antibodies and nucleic acids encoding the same. The invention further relates to compositions and therapeutic methods for use of these antibodies for the treatment and/or prevention of TL1A mediated diseases, disorders or conditions.
公开/授权文献
- US1294841A Telephone system. 公开/授权日：1919-02-18
信息查询
IPC分类:
